Omicron and the future of the Pandemic

Subarna Chakravorty

doi:10.38192/1.7.2.4

Vol. 7 No. 2 (2021), Editorial

Vol. 7 No. 2 (2021)

Omicron and the future of the Pandemic

Editorial

https://doi.org/10.38192/1.7.2.4

Published 2021-12-25

Subarna Chakravorty PhD FRCPath FRCPCH FRCP⁺⁻

Subarna Chakravorty PhD FRCPath FRCPCH FRCP

Kings College Hospital, London, UK

PDF

Keywords

COVID19
SARS-CoV-2
Omicron
Pandemic
Variant

How to Cite

Chakravorty, S. (2021). Omicron and the future of the Pandemic. The Physician, 7(2), 1-3. https://doi.org/10.38192/1.7.2.4

Abstract

The advent of the Omicron variant

https://doi.org/10.38192/1.7.2.4

PDF

References

Huang, C., et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020. 395(10223): p. 497-506.

World Health Organisation. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. 2021 [cited 2021 22/12/2021]; Available from: https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern.

Domingo, E., et al., Mutation Rates, Mutation Frequencies, and Proofreading-Repair Activities in RNA Virus Genetics. Viruses, 2021. 13(9).

World Health Organisation. Update on Omicron. 2021 22/12/2021]; Available from: https://www.who.int/news/item/28-11-2021-update-on-omicron.

Dyer, O., Covid-19: South Africa's surge in cases deepens alarm over omicron variant. BMJ, 2021. 375: p. n3013.

WHO Collaborating Centre for Infectious Disease Modelling, Report 49 - Growth, population distribution and immune escape of Omicron in England, J.I. MRC Centre for Global Infectious Disease Analysis, Imperial College London., Editor. 2021.

Head, E., van Esland, S. https://www.imperial.ac.uk/news/232698/modelling-suggests-rapid-spread-omicron-england/. Imperial College London 2021; Available from: https://www.imperial.ac.uk/news/232698/modelling-suggests-rapid-spread-omicron-england/.

Cele, S., et al., SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. medRxiv, 2021.

Bo, M., Ferreira, I., et al., SARS-CoV-2 Omicron spike mediated immune escape, infectivity and cell-cell fusion. 2021: BIORXIV.

Mahase, E., Covid-19: Pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ, 2021. 375: p. n2713.

Mahase, E., Covid-19: UK approves monoclonal antibody sotrovimab for over 12s at high risk. BMJ, 2021. 375: p. n2990.

McIntyre, P.B., et al., COVID-19 vaccine strategies must focus on severe disease and global equity. Lancet, 2021.

Irwin, A., What it will take to vaccinate the world against COVID-19, in Nature. 2021.

Erman, M., Farge, E., https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-allow-generic-versions-its-covid-19-pill-95-countries-2021-11-16/, in Reuters. 2021.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Sunil Daga PhD, MRCP, MBBS, Indranil Chakravorty MBBS PhD FRCP, JS Bamrah MD FRCPsych FIIOPM, Geeta Menon MBBS MD FRCOpth, Subodh Dave MRCPsych MMed, Subarna Chakravorty MBBS MRCPCH PhD FRCPath, Neeraj Bhala MBBS DPhil FRCPE FRCP, Ramesh Mehta OBE MD FRCPCH, Self-reported Occupational Risk for COVID-19 in Hospital Doctors from Black Asian & Minority Ethnic Communities in UK , The Physician: Vol. 6 No. 1 (2020): Pandemic
Nadia Ibrahim, Sabah Mahmood, Sandra O'Driscoll, Subarna Chakravorty MBBS MRCPCH PhD FRCPath, Effectiveness of a top up transfusion programme in preventing cerebrovascular damage in a birth cohort of sickle cell disease , The Physician: Vol. 6 No. 2 (2020): After the Pandemic
Joydeep Grover MBBS FRCEM, Neeraj Bhala MBBS DPhil FRCPE FRCP, Subarna Chakravorty MBBS MRCPCH PhD FRCPath FRCP, Response to Second Surge, B.1.1.7 variant and UK Policy on COVID-19 , The Physician: Vol. 6 No. 3 (2021): January 2021
Frederik Vivian, Subarna Chakravorty MBBS MRCPCH PhD FRCPath FRCP, Plain film x-rays in the diagnosis of sickle cell limb pain in children , The Physician: Vol. 7 No. 1 (2021): Into a New Beginning
Subarna Chakravorty MBBS MRCPCH PhD FRCPath FRCP, Vaccines against SARS-Cov-2 , The Physician: Vol. 6 No. 3 (2021): January 2021
Subarna Chakravorty MBBS MRCPCH PhD FRCPath, Risk Stratification in COVID-19 , The Physician: Vol. 6 No. 1 (2020): Pandemic
Sneha Bisht, Priyanka Nageswaran, Kantappa Gajanan, Sunil Daga, Subarna Chakravorty, Research & Innovation Abstracts , The Physician: Vol. 7 No. 2 (2021): Post-pandemic Winter Edition
Subarna Chakravorty PhD FRCPath FRCPCH FRCP, Omicron and the future of the Pandemic , The Physician: Vol. 7 No. 2 (2021): Post-pandemic Winter Edition

Omicron and the future of the Pandemic

Keywords

How to Cite

Download Citation

Abstract

References

Similar Articles

Most read articles by the same author(s)